1. World Health Organization. Antimicrobial resistance: global report on surveillance. World Health Organization. 2014. http://apps.who.int/iris/bitstream/handle/10665/112642/?sequence=1. Accessed on 24, September 2018
2. US Department of Health and Human Services. Antibiotic resistance threats in the United States. Centers for Disease Control and Prevention. 2013. https://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Accessed on 24 September, 2018
3. European Centre for Disease Prevention and Control & European Medicines Agency. The Bacterial Challenge: Time to React-A Call to Narrow the Gap Between Multidrug-Resistant Bacteria in the EU and the Development of New Antibacterial Agents. ECDC/EMEA Joint Technical report. 2009. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. Accessed on 25 September, 2018
4. Song J-H, Jung S-I, Ko KS, Kim NY, Son JS, Chang H-H, Ki HK, Oh WS, Suh JY, Peck KR (2004) High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 48(6):2101–2107
5. Chai G, Governale L, McMahon AW, Trinidad JP, Staffa J, Murphy D (2002) Trends of outpatient prescription drug utilization in US children. Pediatrics 2012:2011–2879